as 09-12-2025 4:00pm EST
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
Founded: | 2010 | Country: | United States |
Employees: | N/A | City: | SAN FRANCISCO |
Market Cap: | 10.9B | IPO Year: | 2021 |
Target Price: | $67.53 | AVG Volume (30 days): | 1.2M |
Analyst Decision: | Buy | Number of Analysts: | 19 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 1.17 | EPS Growth: | 45.79 |
52 Week Low/High: | $36.78 - $85.21 | Next Earning Date: | 11-06-2025 |
Revenue: | $589,636,000 | Revenue Growth: | 19.45% |
Revenue Growth (this year): | 13.33% | Revenue Growth (next year): | 10.90% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Wampler Kira Scherer | DOCS | Director | Sep 2 '25 | Sell | $66.57 | 2,000 | $133,140.00 | 19,839 | |
Cabral Timothy S | DOCS | Director | Sep 2 '25 | Sell | $66.30 | 6,360 | $421,655.92 | 3,221 | |
Bryson Anna | DOCS | Chief Financial Officer | Aug 26 '25 | Sell | $66.76 | 40,000 | $2,670,244.00 | 346,925 | |
Cabral Timothy S | DOCS | N/A | Aug 15 '25 | Sell | $63.94 | 20,000 | $1,275,566.22 | 3,221 | |
Benjamin Regina M. | DOCS | N/A | Aug 8 '25 | Sell | $63.00 | 5,000 | $315,000.00 | 16,618 |
DOCS Breaking Stock News: Dive into DOCS Ticker-Specific Updates for Smart Investing
StockStory
22 days ago
StockStory
24 days ago
Zacks
3 months ago
MT Newswires
3 months ago
Zacks
3 months ago
Simply Wall St.
3 months ago
Barrons.com
3 months ago
Argus Research
3 months ago
The information presented on this page, "DOCS Doximity Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.